BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 30924075)

  • 1. Arginine Vasopressin and Posterior Reversible Encephalopathy Syndrome Pathophysiology: the Missing Link?
    Largeau B; Le Tilly O; Sautenet B; Salmon Gandonnière C; Barin-Le Guellec C; Ehrmann S
    Mol Neurobiol; 2019 Oct; 56(10):6792-6806. PubMed ID: 30924075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posterior reversible encephalopathy syndrome.
    Lamy C; Oppenheim C; Mas JL
    Handb Clin Neurol; 2014; 121():1687-701. PubMed ID: 24365441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posterior reversible encephalopathy syndrome: the endothelial hypotheses.
    Marra A; Vargas M; Striano P; Del Guercio L; Buonanno P; Servillo G
    Med Hypotheses; 2014 May; 82(5):619-22. PubMed ID: 24613735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental Models of Posterior Reversible Encephalopathy Syndrome: A Review From Pathophysiology to Therapeutic Targets.
    Largeau B; Bergeron S; Auger F; Salmon Gandonnière C; Jonville-Béra AP; Ehrmann S; Gautier S; Bordet R
    Stroke; 2024 Feb; 55(2):484-493. PubMed ID: 38126184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema.
    Bartynski WS
    AJNR Am J Neuroradiol; 2008 Jun; 29(6):1043-9. PubMed ID: 18403560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune system activation in the pathogenesis of posterior reversible encephalopathy syndrome.
    Chen Z; Shen GQ; Lerner A; Gao B
    Brain Res Bull; 2017 May; 131():93-99. PubMed ID: 28373149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posterior reversible encephalopathy syndrome (PRES) and infection: a systematic review of the literature.
    Racchiusa S; Mormina E; Ax A; Musumeci O; Longo M; Granata F
    Neurol Sci; 2019 May; 40(5):915-922. PubMed ID: 30604335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posterior reversible encephalopathy syndrome in children with kidney disease.
    Gavrilovici C; Miron I; Voroneanu L; Bădărau S; Stârcea M
    Int Urol Nephrol; 2017 Oct; 49(10):1793-1800. PubMed ID: 28836059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Features of infratentorial-predominant posterior reversible encephalopathy syndrome.
    Fitzgerald RT; Samant RS; Kumar M; Van Hemert R; Angtuaco EJ
    Acta Neurol Belg; 2015 Dec; 115(4):629-34. PubMed ID: 25605260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posterior reversible encephalopathy syndrome following a thoracic discectomy-induced dural leak: case report.
    Shields LB; Johnson JR; Shields CB
    J Neurosurg Spine; 2016 Nov; 25(5):586-590. PubMed ID: 27258477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Posterior reversible encephalopathy syndrome].
    Petrović B; Kostić V; Sternić N; Kolar J; Tasić N
    Srp Arh Celok Lek; 2003; 131(11-12):461-6. PubMed ID: 15114789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial blood pressure but not serum albumin concentration correlates with ADC ratio values in pediatric posterior reversible encephalopathy syndrome.
    Furtado A; Hsu A; La Colla L; Zuccoli G
    Neuroradiology; 2015 Jul; 57(7):721-8. PubMed ID: 25845806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posterior reversible encephalopathy syndrome.
    Fischer M; Schmutzhard E
    J Neurol; 2017 Aug; 264(8):1608-1616. PubMed ID: 28054130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posterior reversible encephalopathy syndrome associated with nephrotic syndrome.
    Zhang HL; Yang Y; Wu J
    Neuro Endocrinol Lett; 2010; 31(6):728; author reply 729-30. PubMed ID: 21196919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posterior reversible encephalopathy syndrome: clinicoradiological spectrum and therapeutic strategies.
    Li Y; Jenny D; Castaldo J
    Hosp Pract (1995); 2012 Feb; 40(1):202-13. PubMed ID: 22406896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [PRES: Posterior Reversible Encephalopathy Syndrome].
    Okamoto K; Motohashi K; Fujiwara H; Ishihara T; Ninomiya I; Onodera O; Fujii Y
    Brain Nerve; 2017 Feb; 69(2):129-141. PubMed ID: 28202821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posterior reversible encephalopathy syndrome with extensive cytotoxic edema after blood transfusion: a case report and literature review.
    Nakamura Y; Sugino M; Tsukahara A; Nakazawa H; Yamamoto N; Arawaka S
    BMC Neurol; 2018 Nov; 18(1):190. PubMed ID: 30419835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions.
    Fugate JE; Rabinstein AA
    Lancet Neurol; 2015 Sep; 14(9):914-925. PubMed ID: 26184985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Magnetic Resonance Diffusion-Weighted Imaging Evaluation of the Supratentorial Brain Regions in Patients Diagnosed with Brainstem Variant of Posterior Reversible Encephalopathy Syndrome: A Preliminary Study.
    Chen TY; Wu TC; Ko CC; Feng IJ; Tsui YK; Lin CJ; Chen JH; Lin CP
    J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):1560-1568. PubMed ID: 28341199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticosteroid therapy and severity of vasogenic edema in posterior reversible encephalopathy syndrome.
    Parikh NS; Schweitzer AD; Young RJ; Giambrone AE; Lyo J; Karimi S; Knobel A; Gupta A; Navi BB
    J Neurol Sci; 2017 Sep; 380():11-15. PubMed ID: 28870548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.